Ágnes Kerényi

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study

Yuichiro Ogura, Johann Roider, Jean‐François Korobelnik et al. · American Journal of Ophthalmology · 2014 · 158 citations

Ocular Disease, Vitreous Body, Ophthalmology +6

TENAYA and LUCERNE

Arshad M. Khanani, Aachal Kotecha, Andrew Chang et al. · Ophthalmology · 2024 · 124 citations · Full text

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 105 citations · Full text

Faricimab Treat-and-extend, Diabetic Retinopathy, Ocular Disease +3

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M. Brown, David S. Boyer, V. Diana et al. · The Lancet · 2024 · 78 citations

Diabetic Retinopathy, Ocular Disease, Ophthalmology +5